X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (28) 28
index medicus (28) 28
obesity (16) 16
endocrinology & metabolism (15) 15
male (15) 15
digestive, oral, and skin physiology (14) 14
humans (14) 14
mice (13) 13
food-intake (12) 12
rats (11) 11
ghrelin - metabolism (10) 10
hormones, hormone substitutes, and hormone antagonists (10) 10
abridged index medicus (9) 9
insulin (8) 8
metabolism (8) 8
mice, knockout (8) 8
body weight (7) 7
body-weight (7) 7
eating - drug effects (7) 7
endocrine system (7) 7
endocrinology (7) 7
ghrelin (7) 7
glucose (7) 7
hormone secretagogue receptor (7) 7
physiological aspects (7) 7
diabetes (6) 6
energy-balance (6) 6
ghrelin - pharmacology (6) 6
obesity - metabolism (6) 6
research (6) 6
acylation (5) 5
acyltransferases - metabolism (5) 5
analysis (5) 5
arcuate nucleus (5) 5
article (5) 5
care and treatment (5) 5
eating - physiology (5) 5
energy metabolism - drug effects (5) 5
female (5) 5
glucagon-like peptide-1 receptor (5) 5
glucose - metabolism (5) 5
glucose tolerance test (5) 5
mice, inbred c57bl (5) 5
rats, long-evans (5) 5
receptors, ghrelin - metabolism (5) 5
receptors, glucagon - agonists (5) 5
receptors, glucagon - metabolism (5) 5
unacylated ghrelin (5) 5
acyltransferases - genetics (4) 4
blood glucose - metabolism (4) 4
body composition - drug effects (4) 4
body weight - drug effects (4) 4
eating (4) 4
energy metabolism - physiology (4) 4
glucagon (4) 4
hormones (4) 4
insulin - metabolism (4) 4
insulin-resistance (4) 4
peptide (4) 4
receptors, glucagon - genetics (4) 4
rodents (4) 4
signal transduction - drug effects (4) 4
adipose tissue, brown - metabolism (3) 3
adiposity (3) 3
animal models (3) 3
beta-cells (3) 3
biology (3) 3
body composition (3) 3
brown adipose-tissue (3) 3
cell biology (3) 3
circulating ghrelin (3) 3
des-acyl ghrelin (3) 3
diet, high-fat (3) 3
fibroblast growth factors (3) 3
genetic aspects (3) 3
ghrelin - administration & dosage (3) 3
ghrelin - blood (3) 3
glp-1 (3) 3
glucagon - metabolism (3) 3
glucagon-like peptide 1 - metabolism (3) 3
glucagon-like peptide-1 (3) 3
glucose metabolism (3) 3
growth-hormone (3) 3
health aspects (3) 3
homeostasis (3) 3
infusions, intraventricular (3) 3
insulin resistance (3) 3
insulin-secretion (3) 3
liraglutide (3) 3
models, biological (3) 3
multidisciplinary sciences (3) 3
neuropeptide-y (3) 3
neurosciences (3) 3
obesity - drug therapy (3) 3
phenotype (3) 3
rat-brain (3) 3
receptors, ghrelin - genetics (3) 3
research article (3) 3
signal transduction (3) 3
stimulated insulin-secretion (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Endocrinology, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R21 - R32
Journal Article
Journal Article
Frontiers in neuroscience, ISSN 1662-4548, 2015, Volume 9, p. 92
Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions. In addition to its incretin action, GLP-1 acts... 
Journal Article
European journal of endocrinology / European Federation of Endocrine Societies, ISSN 0804-4643, 2014, Volume 171, Issue 1, pp. R21 - 32
Journal Article
Diabetes, ISSN 0012-1797, 05/2013, Volume 62, Issue 5, pp. 1453 - 1463
Glucagon, an essential regulator of glucose homeostasis, also modulates lipid metabolism and promotes weight loss, as reflected by the wasting observed in... 
PPAR-ALPHA | BODY-WEIGHT | METABOLISM | FIBROBLAST-GROWTH-FACTOR-21 | PHARMACOLOGY | INCREASES ENERGY-EXPENDITURE | ENDOCRINOLOGY & METABOLISM | DEGRADATION | MICE | INSULIN SENSITIVITY | FGF21 | Obesity - drug therapy | Humans | Peptides - pharmacokinetics | Fibroblast Growth Factors - genetics | Male | Fibroblast Growth Factors - secretion | Obesity - blood | Anti-Obesity Agents - therapeutic use | Glucagon - agonists | Fibroblast Growth Factors - metabolism | Anti-Obesity Agents - pharmacokinetics | Peptides - chemical synthesis | Hepatocytes - secretion | Hypoglycemic Agents - therapeutic use | Receptors, Glucagon - agonists | Receptors, Glucagon - genetics | Hypoglycemic Agents - pharmacokinetics | Peptides - physiology | Rats | Hypoglycemic Agents - pharmacology | Mice, Knockout | Cross-Over Studies | Anti-Obesity Agents - chemical synthesis | Mice | Anti-Obesity Agents - pharmacology | Hepatocytes - pathology | Diabetes Mellitus, Type 2 - metabolism | Hepatocytes - metabolism | Molecular Targeted Therapy | Mice, Mutant Strains | HEK293 Cells | Adult | Female | Hepatocytes - drug effects | Recombinant Proteins - metabolism | Double-Blind Method | Cells, Cultured | Insulin Resistance | Receptors, Glucagon - metabolism | Recombinant Proteins - agonists | Glucagon - pharmacology | Obesity - metabolism | Diabetes Mellitus, Type 2 - blood | Animals | Fibroblast Growth Factors - blood | Hypoglycemic Agents - chemical synthesis | Glucagon - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Peptides - therapeutic use | Physiological aspects | Fibroblast growth factors | Research | Glucagon | Analysis | Original Research
Journal Article
Frontiers in Neuroscience, ISSN 1662-4548, 03/2015, Volume 9
Glucagon-like peptide-1 (GLP-1) enhances meal-related insulin secretion, which lowers blood glucose excursions. In addition to its incretin action, GLP-1 acts... 
Obesity | CNS | GLP-1 | Diabetes | Insulin | insulin | FOOD-INTAKE | RECEPTOR AGONISTS | NEUROSCIENCES | ENERGY-BALANCE | BODY-WEIGHT | DIPEPTIDYL PEPTIDASE-4 INHIBITORS | GLUCAGON-LIKE PEPTIDE-1 | CENTRAL-NERVOUS-SYSTEM | ADIPOSE-TISSUE THERMOGENESIS | diabetes | TYPE-2 DIABETES-MELLITUS | obesity | PRIMATE MACACA-MULATTA
Journal Article
Diabetes, ISSN 0012-1797, 11/2012, Volume 61, Issue 11, pp. 2753 - 2762
Journal Article
Science Translational Medicine, ISSN 1946-6234, 10/2013, Volume 5, Issue 209, pp. 209ra151 - 209ra151
We report the discovery and translational therapeutic efficacy of a peptide with potent, balanced co-agonism at both of the receptors for the incretin hormones... 
MEDICINE, RESEARCH & EXPERIMENTAL | BODY-WEIGHT | GLYCEMIC CONTROL | HIGH-FAT DIET | GLUCOSE-INTOLERANCE | ENTEROINSULAR AXIS | PANCREATIC BETA-CELLS | DEPENDENT INSULINOTROPIC POLYPEPTIDE | GASTRIC-INHIBITORY POLYPEPTIDE | LIPOPROTEIN-LIPASE | PEPTIDE YY3-36 | CELL BIOLOGY | Acylation - drug effects | Glucagon-Like Peptide 1 - administration & dosage | Humans | Middle Aged | Male | Rodentia - metabolism | Weight Loss - drug effects | Hyperglycemia - drug therapy | Young Adult | Incretins - pharmacology | Adult | Female | Gastric Inhibitory Polypeptide - pharmacology | Receptors, Glucagon - agonists | Glucose Tolerance Test | Glucagon-Like Peptide 1 - analogs & derivatives | Glucagon-Like Peptide 1 - pharmacology | Rats | Receptors, Glucagon - metabolism | Treatment Outcome | Haplorhini - metabolism | Gastric Inhibitory Polypeptide - administration & dosage | Peptides - pharmacology | Insulin - metabolism | Animals | Glucagon-Like Peptide-1 Receptor | Adolescent | Aged | Mice | Venoms - pharmacology | Incretins - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Receptors, Gastrointestinal Hormone | Incretins - administration & dosage | Liraglutide | Medicin och hälsovetenskap | Medicinsk bioteknologi (inriktn. mot cellbiologi (inkl. stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) | Medicinsk bioteknologi
Journal Article
Journal Article